www.psychiatriepropraxi.cz e7 PŘEHLEDOVÉ ČLÁNKY Močová retence jako vzácná komplikace užívání psychofarmak PSYCHIATRIE PRO PRAXI 6. Hwang YJ, Dixon SN, Reiss JP, et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Annals of internal medicine 2014; 161(4): 242–248. 7. Lin YT. Urinary retention as a rare adverse effect of clozapine: a case report. In International Journal of Neuropsychofarmacology 2016; 19: 196–197. 8. Cohen R, Wilkins KM, Ostroff R, et al. Olanzapine and acute urinary retention in two geriatric patients. The American journal of geriatric pharmacotherapy 2007; 5(3): 241–246. 9. Sokolski KN, Brown BJ, Melden M. Urinary retention following repeated high-dose quetiapine. Annals of Pharmacotherapy 2004; 38(5): 899–900. 10. Chung AK, Chua SE. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone. Illin Psychopharmacol 2007; 27(5): 517–519. 11. Kopeček M. Preskripce psychofarmak a jejich ceny v ČR v letech 2003, 2005 a 2008. Čes a slov psychiatr 2010; 106(2): 119–120. 12. Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004; 37(S1): 39–45. 13. Biederman J, Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. Journal of clinical psychopharmacology 1985; 5(1): 10–16. 14. Güloğlu C, Orak M, Üstündağ M, et al. Analysis of amitriptyline overdose in emergency medicine. Emergency Medicine Journal 2011; 28(4): 296–299. 15. Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. American family physician 2008; 77(5). 643–650. 16. Claghorn JL, Earl CQ, Walczak DD, et al. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. Journal of clinical psychopharmacology 1996; 16(2): 113–120. 17. Yoshimura N, Chancellor MB. Neurophysiology of lower urinary tract function and dysfunction. Reviews in urology 2003; 5: 3. 18. Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: Results of the German multicenter drug surveillance program AMPS. Pharmacopsychiatry 2004; 37: 39–45. 19. Movig KLL, Leufkens HGM, Belitser SV, et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiology and drug safety 2002; 11(4): 271–279. 20. Cannon TW, Chancellor MB. Pharmacotherapy for stress urinary incontinence. Rev Urol. 2003; 5: 135–141. 21. Viktrup L, Pangallo BA, Detke MJ, et al. Urinary side effects of duloxetine in the treatment of depression and stress urinary incontinence. Prim Care Companion J Clin Psychiatry 2004; 6: 65–73. 22. Çaksen H, Odabaş D. Urinary retention due to clonazepam in a child with dyskinetic cerebral palsy. Journal of Emergency Medicine 2004; 26(2): 244. 23. Steiner I, Birmanns B. Carbamazepine-induced urinary retention in long-standing diabetes mellitus. Neurology 1993; 43(9): 1855–1855. 24. Filling-Katz MR, Merrick HF, Fink JK, et al. Carbamazepine in Fabry's disease: Effective analgesia with dose-dependent exacerbation of autonomic dysfunction. Neurology 1989; 39(4): 598–598. 25. Hmouda H, Salem CB, Grira M, et al. Carbamazepine-induced urinary retention. British journal of clinical pharmacology 2007; 64(6): 833. 26. Burger DH, Kappetein AP, Boutkan H, et al.. Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine. Journal of the American College of Surgeons 1997; 185(3): 234–236.
RkJQdWJsaXNoZXIy NDA4Mjc=